LoginSignup
Resmed logo

Resmed

Stock
Stock
Ticker: RMD
RMD

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Resmed has so far distributed $1.20 in 2026. The next dividend will be paid on 24.09.2026

$1.581

CHART BY

Frequently asked questions

What is Resmed's market capitalization?

The market capitalization of Resmed is $33.47B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Resmed's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Resmed is 22.25. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Resmed?

Resmed's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $10.44. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Resmed's stock?

Currently, 31 analysts cover Resmed's stock, with a consensus target price of $259.74. Analyst ratings provide insights into the stock's expected performance.

What is Resmed's revenue over the trailing twelve months?

Over the trailing twelve months, Resmed reported a revenue of $5.65B.

Is Resmed paying dividends?

Yes, Resmed is paying dividends. The next payment is scheduled for 24.09.2026, with an expected amount of .

What is the EBITDA for Resmed?

Resmed's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $2.17B. EBITDA measures the company's overall financial performance.

What is the free cash flow of Resmed?

Resmed has a free cash flow of $1.65B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does Resmed have, and what sector and industry does it belong to?

Resmed employs approximately 11,370 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.

What is the free float of Resmed's shares?

The free float of Resmed is 142.89M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$33.47B
EPS (TTM) 
$10.44
Free Float 
142.89M
P/E ratio (TTM) 
22.25
Revenue (TTM) 
$5.65B
EBITDA (TTM) 
$2.17B
Free Cashflow (TTM) 
$1.65B

Pricing

1D span
$228.27$234.04
52W span
$180.41$293.38

Analyst Ratings

The price target is $259.74 and the stock is covered by 31 analysts.

Buy

19

Hold

10

Sell

2

Information

ResMed, Inc. engages in the design, manufacture, and marketing of equipment for the diagnosis and treatment of sleep-disordered breathing and other respiratory disorders, as well as the provision of software solutions for residential care providers. It operates through the following segments: Sleep and Breathing Health and Residential Care Software. The Sleep and Breathing Health segment relates primarily to the sale of therapy-based equipment. The Residential Care Software segment provides software access with ongoing support and maintenance services as well as professional services such as training and consulting. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.

Employees
11,370
Industries
Medical Specialties
Sector
Health Care

Identifier

Primary Ticker
RMD

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation
Sign upLogin